Subtype
Adrenal Gland Neoplasm
CI-CAN-00000413Explore in graph →
Non-malignant54 active trials1 approved drugs4 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000413Explore in graph →
Clinical trials
262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03015844 | A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma | available | — | — | Northwell HealthOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT01163383 | 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol | available | — | — | John MarisOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT01590680 | Expanded Access Protocol Using 131I-MIBG | available | — | — | Jubilant DraxImage Inc.INDUSTRY | 1 | Feb 28, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 6, 2026source: clinicaltrials